HG. Kraetsch, T. Hummel; J. Lötsch; R. Kussat; G. Kobal, Analgesic effects of propyphenazone in comparison to its combination with caffeine., in Eur J Clin Pharmacol, vol. 49, n. 5, 1996, pp. 377-82, PMID 8866632.
E Göres, , Kossowicz J, Schneider HG., [Propyphenazone. Pharmacology and use]., in Med Monatsschr Pharm., vol. 27, n. 1, Set 2004, pp. 72-6, PMID 15032249.
M. Volz, HM. Kellner, Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone)., in Br J Clin Pharmacol, 10 Suppl 2, Ott 1980, pp. 299S-308S, PMID 7002187.
A. Moosmayer, K. Besserer, [Blood and urine concentrations following intake of propyphenazone]., in Beitr Gerichtl Med, vol. 40, 1982, pp. 335-9, PMID 7165655.
V. Boerlin, B. Maeglin; W. Hägler; M. Kuhn; E. Nüesch, Analgesic activity of propyphenazone in patients with pain following oral surgery., in Eur J Clin Pharmacol, vol. 31, n. 2, 1986, pp. 127-31, PMID 3492378.
M. Himly, B. Jahn-Schmid; K. Pittertschatscher; B. Bohle; K. Grubmayr; F. Ferreira; H. Ebner; C. Ebner, IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone., in J Allergy Clin Immunol, vol. 111, n. 4, Apr 2003, pp. 882-8, PMID 12704373.
A. Rubio-Martínez, JA. García-Erce; C. Salvador; E. Gómez-Arteta; JJ. Gimeno, Autoimmune haemolytic anaemia induced by propyphenazone., in Vox Sang, vol. 75, n. 3, 1998, p. 257, PMID 9852417.
F. Hincal, AA. Hincal; Y. Müftü; F. Sarikayalar; Y. Ozer; N. Cevik; E. Kinik, Epidemiological aspects of childhood poisonings in Ankara: a 10-year survey., in Hum Toxicol, vol. 6, n. 2, Mar 1987, pp. 147-52, PMID 3557472.
F. Hincal, AA. Hincal; F. Sarikayalar; N. Cevik; E. Kinik, Self poisoning in children: a ten year survey., in J Toxicol Clin Toxicol, vol. 25, n. 1-2, 1987, pp. 109-20, PMID 3586081.